SlidesetHIVAsia-Pacific HIV Clinical Forum 2020David Back | HIV Gender & Ethnicity - Implications for Toxicity and Altered PharmacologyView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Kiat Ruxrungtham | Two Versus Three Drugs - Relevance for the Asian SettingsView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Opass Putcharoen | HIV Subtypes - Virologic and Resistance ImplicationsView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Stephane Wen-Wei Ku | PrEP Implementation in Real-Life (Case-Based Presentation)View Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Sasisopin Kiertiburanakul | Opening Lecture: HIV Drug Resistance in AsiaView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Iskandar Azwa | Implementation of PrEP - Social Aspects and STI Risk CompensationView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Jean-Michel Molina | Implementation of PrEP - Efficacy and Resistance ConsiderationsView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2020Sivaporn Gatechompol | Selected Treatment Highlights - CROI 2020 - Regional RelevanceView Slideset
SlidesetHIVWorkshop on Healthy Living with HIV 2020Meet Marvin, the Chatbot: Using Artificial Intelligence to Engage HIV Patients in their Antiretroviral Therapy - Yuanchao MAView Slideset
SlidesetHIVWorkshop on Healthy Living with HIV 2020Tele-counseling Helps Maintain Employee Productivity and Patient Reach in the Context of the COVID-19 Pandemic for HIV Patients from Baylor Black Sea Foundation (BBSF), Romania - Elena RizeaView Slideset
